Search

Betamethasone phosphate

[L11994] Betamethasone sodium phosphate was granted FDA approval on 3 March 1965.[L11994] … Betamethasone phosphate is a prodrug that is rapidly hydrolyzed, providing rapidly accessible [betamethasone] to agonize glucocorticoid receptors.

Pargyline

Pargyline is a monoamine oxidase inhibitor with antihypertensive properties.

Black cohosh

European settlers were said to use black cohosh as a tonic to support female reproductive health. … [A32543] The American College of Obstetrics and Gynecology guidelines on the use of botanicals, such as black cohosh, for the management of menopausal symptoms the use of for up to six months, especially

Pazopanib

It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.

Efalizumab

Humanized IgG1 kappa isotype monoclonal antibody that binds to human CD11a. … It was later withdrawn in 2009 due to a potential risk of progressive multifocal leukoencephalopathy (PML).[L43797]

Scorpion (centruroides) immune Fab2 antivenin (equine)

Envenomation by a scorpion sting can result in serious cardiovascular effects [A32483]. … It was approved by FDA in 2011 and is marketed under the name Anascorp [L2196]. Anascorp is produced from equine IgG antibodies.

Botulinum toxin type B

Neurotoxin produced by fermentation of clostridium botulinum type B. The protein exists in noncovalent association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin complex.

Sonidegib

Sonidegib is a Hedgehog signaling pathway inhibitor (via smoothened antagonism) developed as an anticancer agent by Novartis. It was FDA approved in 2015 for the treatment of basal cell carcinoma.

Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen

Propylhexedrine

It is used to give temporary relief for nasal congestion from colds, allergic rhinitis, or allergies.